Yu Chen

Direktör/Styrelseledamot på

Genor Biopharma Co., Ltd.

45 år

97 relationer

Health Technology

Consumer Services

Commercial Services

Profil

Yu Chen is currently a Director at Genor Biopharma Co., Ltd. and PharmaLegacy Laboratories (Shanghai) Co., Ltd. Previously, he held positions as a Director at Suzhou NanoMicro Technology Co. Ltd., GemPharmatech Co., Ltd., Genor Biopharma Holdings Ltd., and Zhaoke Ophthalmology Ltd. He also worked as an Associate at Citigroup Global Markets Asia Ltd. and as a Senior Manager-Investment at Shanghai Panxin Equity Investment Management Co. Ltd. Mr. Chen received his graduate degree from Stanford University in 2008, his graduate degree from Yale University in 2005, and his undergraduate degree from The Hong Kong University of Science & Technology in 2003.

Aktiva positioner av Yu Chen

Företag	Position	Start
Genor Biopharma Co., Ltd. Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Manufactures and develops antibodies and related biological products	Direktör/Styrelseledamot	-
PharmaLegacy Laboratories (Shanghai) Co., Ltd. PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services	Direktör/Styrelseledamot	2021-07-01

Alla aktiva positioner av Yu Chen

Tidigare kända positioner av Yu Chen

Företag	Position	Slut
ZHAOKE OPHTHALMOLOGY LIMITED	Direktör/Styrelseledamot	2024-04-08
EDDING GENOR GROUP HOLDINGS LIMITED	Direktör/Styrelseledamot	2024-01-02
GEMPHARMATECH CO., LTD.	Direktör/Styrelseledamot	2023-04-04
SUZHOU NANOMICRO TECHNOLOGY CO., LTD.	Direktör/Styrelseledamot	2022-03-30
Shanghai Panxin Equity Investment Management Co. Ltd.	Chef för investeringar	2015-07-01

Se detaljerna i Yu Chens erfarenhet

Yu Chens utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Yu Chens erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	11
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Hong Kong University of Science & Technology The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Citigroup Global Markets Asia Ltd. Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
Genor Biopharma Co., Ltd. Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Manufactures and develops antibodies and related biological products	Health Technology
Shanghai Panxin Equity Investment Management Co. Ltd.
Suzhou NanoMicro Technology Co. Ltd. Suzhou NanoMicro Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research & development, production and sales of nano and microsphere materials	Commercial Services
PharmaLegacy Laboratories (Shanghai) Co., Ltd. PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services	Commercial Services
GemPharmatech Co., Ltd. GemPharmatech Co., Ltd. BiotechnologyHealth Technology Specializing in the research and development of humanized models and drug screening technologies	Health Technology
Zhaoke Ophthalmology Ltd. Zhaoke Ophthalmology Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies ophthalmic topical drugs	Health Technology
Genor Biopharma Holdings Ltd. Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs	Health Technology